Evaluation the effect of simvastatin on vitiligo

Evaluation the effect of simvastatin plus hair follicle transplantation on patients diagnosed as refractory vitiligo

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017062425407N4

Enrollment

Registered

2017-07-11

Start date

2017-05-31

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo. vitiligo

Interventions

Intervention 1: Intervention group simvastatin, Tab 40 mg, oral, once a day for 3 months. Intervention 2: Control group Without Placebo.

Treatment - Drugs

Intervention group simvastatin, Tab 40 mg, oral, once a day for 3 months

Control group Without Placebo

Eligibility

Sex/Gender

All

Age

12 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria All patients aged 12-60 years old with refractory vitiligo lesions which do not progress in the last three months, patients with Fitzpatrick skin phototypes (SPT) III to V Exclusion Criteria pregnant and lactating women

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Perifollicular repigmentation. Timepoint: before and end of the first, second and third month of the study. Method of measurement: milimeter by using Caliper.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Amir Feily

Jahrom University of Medical Sciences

edu@jums.ac.ir+98 71 5433 6085

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026